Drug Shortage Report for ALVESCO
| Report ID | 22634 |
| Drug Identification Number | 02285614 |
| Brand name | ALVESCO |
| Common or Proper name | ciclesonide |
| Company Name | ASTRAZENECA CANADA INC |
| Active Ingredient(s) | CICLESONIDE |
| Strength(s) | 200MCG |
| Dosage form(s) | AEROSOL, METERED DOSE |
| Route of administration | INHALATION |
| Packaging size | 120 doses |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-10-06 |
| Actual start date | |
| Estimated end date | 2017-10-20 |
| Actual end date | 2017-10-02 |
| Shortage status | Avoided shortage |
| Updated date | 2017-10-02 |
| Company comments | |
| Health Canada comments | |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.